| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Sucralfate poisoning |
Causative agent (attribute) |
True |
Sucralfate (substance) |
Inferred relationship |
Some |
1 |
| Accidental sucralfate poisoning |
Causative agent (attribute) |
False |
Sucralfate (substance) |
Inferred relationship |
Some |
|
| Intentional sucralfate poisoning |
Causative agent (attribute) |
False |
Sucralfate (substance) |
Inferred relationship |
Some |
|
| intoxication par le sucralfate d'intention indéterminée |
Causative agent (attribute) |
False |
Sucralfate (substance) |
Inferred relationship |
Some |
1 |
| Sucralfate adverse reaction |
Causative agent (attribute) |
True |
Sucralfate (substance) |
Inferred relationship |
Some |
1 |
| Allergy to sucralfate |
Causative agent (attribute) |
False |
Sucralfate (substance) |
Inferred relationship |
Some |
|
| Sucralfate overdose |
Causative agent (attribute) |
True |
Sucralfate (substance) |
Inferred relationship |
Some |
1 |
| Accidental sucralfate overdose (disorder) |
Causative agent (attribute) |
True |
Sucralfate (substance) |
Inferred relationship |
Some |
1 |
| Intentional sucralfate overdose |
Causative agent (attribute) |
True |
Sucralfate (substance) |
Inferred relationship |
Some |
1 |
| surdose de sucralfate d'intention indéterminée |
Causative agent (attribute) |
False |
Sucralfate (substance) |
Inferred relationship |
Some |
1 |
| Sucralfate 200 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sucralfate (substance) |
Inferred relationship |
Some |
|
| Product containing precisely sucralfate 1 gram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sucralfate (substance) |
Inferred relationship |
Some |
|
| Sucralfate 1g suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sucralfate (substance) |
Inferred relationship |
Some |
|
| Sucralfate 1mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sucralfate (substance) |
Inferred relationship |
Some |
|
| Product containing precisely sucralfate 100 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sucralfate (substance) |
Inferred relationship |
Some |
|
| Product containing sucralfate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sucralfate (substance) |
Inferred relationship |
Some |
1 |
| Accidental sucralfate poisoning |
Causative agent (attribute) |
True |
Sucralfate (substance) |
Inferred relationship |
Some |
1 |
| Intentional sucralfate poisoning |
Causative agent (attribute) |
True |
Sucralfate (substance) |
Inferred relationship |
Some |
1 |
| Allergy to sucralfate |
Causative agent (attribute) |
True |
Sucralfate (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely sucralfate 1 gram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sucralfate (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely sucralfate 1 gram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sucralfate (substance) |
Inferred relationship |
Some |
1 |
| Technetium (99m-Tc) sucralfate (substance) |
Is a |
True |
Sucralfate (substance) |
Inferred relationship |
Some |
|
| Product containing precisely sucralfate 1 gram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sucralfate (substance) |
Inferred relationship |
Some |
1 |
| Sucralfate 200 mg/mL oral suspension |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sucralfate (substance) |
Inferred relationship |
Some |
1 |
| Sucralfate 200 mg/mL oral suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sucralfate (substance) |
Inferred relationship |
Some |
1 |
| Product containing sucralfate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sucralfate (substance) |
Inferred relationship |
Some |
1 |
| Product containing only sucralfate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sucralfate (substance) |
Inferred relationship |
Some |
1 |
| Sucralfate only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sucralfate (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely sucralfate 100 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sucralfate (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely sucralfate 100 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sucralfate (substance) |
Inferred relationship |
Some |
1 |
| Product containing lidocaine and metronidazole and sucralfate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sucralfate (substance) |
Inferred relationship |
Some |
2 |
| Product containing only lidocaine and metronidazole and sucralfate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sucralfate (substance) |
Inferred relationship |
Some |
2 |
| Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sucralfate (substance) |
Inferred relationship |
Some |
2 |
| Product containing only lidocaine and metronidazole and sucralfate in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sucralfate (substance) |
Inferred relationship |
Some |
2 |
| Lidocaine hydrochloride 40 mg/g and metronidazole 10 mg/g and sucralfate 70 mg/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sucralfate (substance) |
Inferred relationship |
Some |
2 |
| Lidocaine hydrochloride 40 mg/g and metronidazole 10 mg/g and sucralfate 70 mg/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sucralfate (substance) |
Inferred relationship |
Some |
2 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]